U.S. Supreme Court Halts Nationwide Ban on Abortion Pill

The U.S. Supreme Court issued a 7‑2 decision to temporarily block a May 1 ruling by the 5th U.S. Circuit Court of Appeals that would have ended mail‑order and telemedicine distribution of the abortion medication mifepristone. The appellate ruling stemmed from a lawsuit filed by Alliance Defending Freedom on behalf of Louisiana that challenged FDA regulations allowing remote prescriptions. Two manufacturers, Danco Laboratories and GenBioPro, filed an emergency request that kept the pill’s nationwide access on hold until the Supreme Court’s intervention.

The high court’s order preserves access for millions of Americans who rely on telehealth to obtain the drug, which accounts for more than 60% of abortions in the United States. Justices Clarence Thomas and Samuel Alito dissented, invoking the 1873 Comstock Act to argue that mailing the medication constitutes a “criminal enterprise.” Reproductive‑rights groups hailed the ruling as a temporary victory for patients, especially those in marginalized communities who would otherwise face travel barriers to in‑person dispensing.